Transcode Therapeutics begins dosing in fourth cohort of Phase 1 cancer trial
TransCode Therapeutics (RNAZ) announced that the first patient in Cohort 4 of its Phase I clinical trial has received their initial dose.
Aura Biosciences announces data from Phase 1 trial of bel-sar in NMIBC
Aura Biosciences (AURA) announced data from a completed Phase 1 window of opportunity trial of bel-sar in patients with NMIBC. These data were ...
Pulmonary Hypertension News9 天
Corsair planning Phase 1 trial of treprostinil skin patch for PAH
Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).